{"id":652650,"date":"2023-05-23T21:02:01","date_gmt":"2023-05-23T21:02:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=652650"},"modified":"2023-05-23T21:02:01","modified_gmt":"2023-05-23T21:02:01","slug":"pyelonephritis-market-to-grow-substantially-during-the-forecast-period-20222032-delveinsight-key-companies-allecra-entasis-wockhardt-sinovent-nabriva-venatorx-spero-therapeutics-melinta","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/pyelonephritis-market-to-grow-substantially-during-the-forecast-period-20222032-delveinsight-key-companies-allecra-entasis-wockhardt-sinovent-nabriva-venatorx-spero-therapeutics-melinta_652650.html","title":{"rendered":"Pyelonephritis Market to Grow Substantially During the Forecast Period (2022-2032) – DelveInsight | Key Companies – Allecra, Entasis, Wockhardt, Sinovent, Nabriva, VenatoRx, Spero Therapeutics, Melinta"},"content":{"rendered":"
\n
\"Pyelonephritis<\/a><\/div>\n
\n
Delveinsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Pyelonephritis Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Pyelonephritis market size, share, trends, and growth opportunities in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).<\/div>\n

The Pyelonephritis market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice\/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. <\/em><\/p>\n

Pyelonephritis: An Overview<\/strong><\/p>\n

According to the National Institute of Diabetes and Digestive and Kidney Diseases, Pyelonephritis (Kidney infection) is an infection of the kidney that most often occurs when a urinary tract infection spreads beyond the bladder to the ureters and kidneys.<\/p>\n

The most common cause of the disease is bacterial infection and based on the severity it is classified into acute and chronic pyelonephritis. The main cause of acute pyelonephritis is gram-negative bacteria, the most common being Escherichia coli. Other gram-negative bacteria which cause acute pyelonephritis include Proteus, Klebsiella, and Enterobacter. Acute pyelonephritis can be further subdivided into uncomplicated and complicated pyelonephritis.<\/p>\n

Pyelonephritis Market Key Facts<\/strong><\/p>\n